|
(V551) |
Ventricular-Arterial Coupling in Heart Failure with preserved Ejection Fraction – Importance of Sympathetic Tone – Insights from Computer Modeling. |
| |
|
K.-P. Rommel, S. Pagoulatou, K.-P. Kresoja, S. Rosch, A. Schöber, M. von Roeder, H. Thiele, K. Fengler, N. Stergiopulos, P. Lurz (Leipzig; Lausanne, CH) |
|
|
Diskussion |
|
(V552) |
Proportion of patients with decompensated heart failure and LVEF above 40% fulfilling eligibility criteria of large HFpEF/HFmrEF outcome trials – a retrospective cohort analysis |
| |
|
V. Santner, H. Riepl, P. Kreuzer, M. Wallner, P. P. Rainer, J. Petutschnigg, A. Lueger, B. Pieske, A. Zirlik, F. Edelmann, N. Verheyen (Graz, AT; Berlin) |
|
|
Diskussion |
|
(V553) |
Empagliflozin does not change cardiac output but reduces acute kidney damage in patients with acute heart failure: a randomized controlled study |
| |
|
K. Thiele, M. Rau, N.-U. Hartmann, M. Marcus, J. Möllmann, J. Jankowski, A. Keszei, M. Böhm, N. Marx, M. Lehrke (Aachen, Homburg/Saar) |
|
|
Diskussion |
|
(V554) |
Absolute Treatment Effects of Novel Oral Antidiabetic Drugs on Cardiovascular Mortality and Hospitalization for Heart Failure – A Meta-Analysis of Digitalized Individual Patient Outcomes |
| |
|
G. Wolff, Y. Lin, M. Brockmeyer, C. Parco, A. Hoss, A. Sokolowski, R. Westenfeld, M. Kelm, M. Rodenbach, M. Roden, C. Akbulut, S. Schlesinger, O. Kuß (Düsseldorf, Mannheim) |
|
|
Diskussion |
|
(V555) |
Application of digital twin of the heart-technology in cardiac electrophysiology |
| |
|
J. Müller, T. Passerini, T. Mansi, M. Haschemi, T. Deneke (Bad Neustadt a. d. Saale, Forchheim; Princeton, US) |
|
|
Diskussion |
|
(V556) |
Hydrochlorothiazide did not lead to phototoxic reactions and DNA-damage in healthy volunteers - the "HCTox-Study" |
| |
|
F. Götzinger, L. Lauder, D. Millenaar, M. Hohl, C. Ukena, F. Mahfoud, M. Meyer, J. Reichrath, M. Böhm (Homburg/Saar, Homburg) |
|
|
Diskussion |